Bausch & Lomb gets $640 million acquisition funds:
This article was originally published in Clinica
Bausch & Lomb, which has identified eye health as its core business, has disposed of its fashion sunglasses businesses, for $640 million and plans to plough some of the profit back into further acquisitions. The company says it will pay off debt in the short term, but will also continue building its eye-care business. In 1997 B&L bought Storz Instruments and Chiron Vision. Its Miracle Aid hearing aid business is also set for disposal before the end of the year.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.